(Q42407267)

29 October 2017

Agonist and antagonist effects of Sar1-ala8--angiotensin II in salt-loaded and salt-depleted normal man (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A973974

11 August 2022

author name string

MacGregor GA

series ordinal

1

1 reference

29 October 2017

G. A. MacGregor

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A973974

11 August 2022

P. M. Dawes

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A973974

11 August 2022

publication date

1 June 1976

1 reference

full work available at URL

29 October 2017

language of work or name

English

0 references

https://europepmc.org/articles/PMC2958757

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A973974

https://europepmc.org/articles/PMC2958757?pdf=render

11 August 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A973974

British Journal of Clinical Pharmacology

11 August 2022

published in

1 reference

29 October 2017

3

1 reference

29 October 2017

3

1 reference

29 October 2017

483-487

1 reference

ANGIOTENSIN II, NOREPINEPHRINE, AND RENAL TRANSPORT OF ELECTROLYTES AND WATER IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES.

29 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958757

Estimation of angiotensin II concentration in human plasma by radioimmunoassay. Some applications to physiological and clinical states

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958757

Use of an Angiotensin II Antagonist (Saralasin) in the Recognition of “Angiotensinogenic” Hypertension

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958757

Characterization of smooth muscle receptors for angiotensin: studies with an antagonist

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2958757

Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure

28 May 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/973974

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The effect of angiotension on urine flow and electrolyte excretion in hypertensive patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/973974

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.1976.TB00625.X

1 reference

29 October 2017

1 reference

29 October 2017

1 reference